Prostate Cancer — Proceedings from a Session Held in Conjunction with the 2026 American Urological Association Annual Meeting
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
Prostate Cancer — Proceedings from a Session Held in Conjunction with the 2026 American Urological Association Annual Meeting
-
Narrated by:
-
By:
Featuring perspectives from Dr Neeraj Agarwal, Dr Elisabeth I Heath, Dr Daniel P Petrylak, Dr Fred Saad and Dr Neal D Shore, moderated by Dr Heath, including the following topics:
- Introduction (0:00)
- Evolving Management of Nonmetastatic Hormone-Sensitive Prostate Cancer (HSPC) — Dr Shore (2:12)
- Current Hormonal Treatment for Metastatic HSPC (mHSPC) — Dr Petrylak (27:54)
- Current and Future Role of PARP Inhibitors for Metastatic Prostate Cancer (mPC) — Dr Agarwal (50:49)
- Emerging Role of AKT Inhibition for Patients with mHSPC — Dr Heath (1:13:12)
- Current and Future Use of Radiopharmaceuticals for mPC — Dr Saad (1:37:26)
CME information and select publications
adbl_web_anon_alc_button_suppression_t1
No reviews yet